Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
JBIO is expected to report earnings to rise 15.75% to -65 cents per share on November 16
Q3'26
Est.
$-0.66
Q1'26
Beat
by $0.10
Q4'25
Missed
by $0.33
Q3'25
Missed
by $0.23
Q2'25
Missed
by $0.55
The last earnings report on May 07 showed earnings per share of -56 cents, beating the estimate of -67 cents. With 1.00M shares outstanding, the current market capitalization sits at 1.21B.